Systemic Sclerosis DIet for GastrointESTinal Symptoms
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan
- Study ID
- NCT07402226
- Status
- Recruiting
Conditions
- Systemic Sclerosis (SSc)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Diet 1: Restriction of fermentable carbohydrates — BEHAVIORAL6 weeks guided diet under the supervision of a dietician restricting fermentable carbohydrates known to trigger GI symptoms.
- Diet 2: Elimination of foods harmful to gut barrier and microbiome — BEHAVIORAL6 weeks guided diet under the supervision of a dietician eliminating of foods harmful to gut barrier and microbiome
- Diet 3: Regular meal patterns, soluble fiber, and portion control — BEHAVIORAL6 weeks guided diet under the supervision of a dietician emphasizing regular meal patterns, soluble fiber, and portion control.
Study Details
This research will evaluate the effect of diets on bloating/distention, assess changes in abdominal pain, and overall gastrointestinal symptom burden in Systemic Sclerosis. The researchers will do this by comparing outcomes of people assigned to 3 different diets. Following the research specifics of the diets will be available upon contact with the details listed below.
Key Dates
- Start date
- Mar 16, 2026
- Status verified
- Mar 2026
- Primary completion
- Apr 30, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Diet 1: Restriction of fermentable carbohydrates
- Experimental: Diet 2: Elimination of foods harmful to gut barrier and microbiome
- Experimental: Diet 3: Regular meal patterns, soluble fiber, and portion control
Primary Outcome Measure
Change in Bloating severity [ Time Frame: Baseline to week 6 ]
Central Contacts
- Rosemary Gedert734-764-6466
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan | Ann Arbor | Michigan | 48109 | Dinesh Khanna, MD, MSc (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Ann Arbor, MI
By research site
Related Studies
- TENS in SclerodermaPHASE1 · Recruiting · University of Michigan · Ann Arbor, Michigan
- A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic SclerosisPHASE2 · Recruiting · argenx · Phoenix, Arizona
- The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of LifeRecruiting · Robyn T. Domsic, MD, MPH · New Orleans, Louisiana
- Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)PHASE2 · Recruiting · Zura Bio Inc · La Jolla, California